HTI Insider Trading Activity and SEC Form 4 Filings
HTI insider trading summary
No open-market insider purchases or sales of Halozyme Therapeutics Inc (HTI) have been reported on SEC Form 4 in the past 12 months.
Latest HTI insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 17, 2007 | Randal J Kirk | Director | Buy | $2.1M (238,020 @ $8.66) |
| Sep 14, 2007 | Randal J Kirk | Director | Buy | $1.1M (127,693 @ $8.71) |
| Sep 13, 2007 | Randal J Kirk | Director | Buy | $574K (65,713 @ $8.74) |
| May 30, 2007 | Randal J Kirk | Director | Buy | $32.1M (3,500,000 @ $9.17) |
| May 14, 2007 | David A Ramsay | Secretary, CFO | Sell | $102K (10,000 @ $10.19) |
| May 7, 2007 | Kenneth J Kelley | Director | Sell | $2K (200 @ $10.37) |
| May 7, 2007 | Kenneth J Kelley | Director | Sell | $32K (3,076 @ $10.38) |
| May 7, 2007 | Kenneth J Kelley | Director | Sell | $4K (400 @ $10.36) |
| May 7, 2007 | Kenneth J Kelley | Director | Sell | $9K (900 @ $10.42) |
| May 7, 2007 | Kenneth J Kelley | Director | Sell | $3K (300 @ $10.35) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.